Sports Medicine

, Volume 34, Issue 8, pp 487–499 | Cite as

The Benefits of Exercise Training for Quality of Life in HIV/AIDS in the Post-HAART Era

  • Joseph T. CiccoloEmail author
  • Esbelle M. Jowers
  • John B. Bartholomew
Leading Article


The use of highly active antiretroviral therapy (HAART) has served to significantly reduce the mortality of HIV-infected persons. However, this treatment is associated with a host of adverse effects: fatigue, nausea, pain, anxiety and depression. Rather than utilise traditional pharmacological treatments for these effects, many HIV/AIDS patients are utilising adjunct therapies to maintain their quality of life while they undergo treatment. Exercise has consistently been listed as one of the most popular self-care therapies and a small number of studies have been conducted to examine the impact of exercise on the most common self-reported symptoms of HIV and AIDS and the adverse effects of treatment. Although the results are generally positive, there are clear limitations to this work. The existing studies have utilised small samples and experienced high rates of attrition. In addition, the majority of the studies were conducted prior to the widespread use of HAART, which limits the ability to generalise these data. As a result, data from other chronic disease and healthy samples are used to suggest that exercise has the potential to be a beneficial treatment across the range of symptoms and adverse effects experienced by HIV-infected individuals. However, additional research is required with this population to demonstrate these effects.


Chronic Obstructive Pulmonary Disease Exercise Training Chronic Fatigue Syndrome Depressed Mood Aerobic Exercise 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.


  1. 1.
    Nuesch R, Geigy N, Schaedler E, et al. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21: 684–7PubMedGoogle Scholar
  2. 2.
    Palella Jr FJ, Chmiel JS, Moorman AC, et al. The HIV Outpatient Study Investigators. Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS 2002; 16: 1617–26Google Scholar
  3. 3.
    Miller V, Sabin CA, Phillips AN, et al. The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load. AIDS 2000; 14: 2129–36PubMedGoogle Scholar
  4. 4.
    Porter K. Survival after introduction of HAART in people with known duration of HIV-1 infection. Lancet 2000; 355: 1158–9Google Scholar
  5. 5.
    Hicks C, Currier J, Sax P, et al. Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications. AIDS Patient Care STDS 2003; 17: 221–33PubMedGoogle Scholar
  6. 6.
    Horwath E. Psychiatric and neuropsychiatric manifestations of HIV infection. J Int Assoc Physicians AIDS Care 2002; 1Suppl. 1: S3–15Google Scholar
  7. 7.
    Roberts KJ. Barriers to and facilitators of HIV-positive patients’ adherence to antiretroviral treatment regimes. AIDS Patient Care STDS 2000; 14: 155–68PubMedGoogle Scholar
  8. 8.
    Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001; 33: 865–72PubMedGoogle Scholar
  9. 9.
    Cinti SK. Adherence to antiretrovirals in HIV disease. AIDS Readings 2000; 10: 709–17Google Scholar
  10. 10.
    Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000; 30Suppl. 2: 171S–6Google Scholar
  11. 11.
    Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS 2003; 17: 169–77PubMedGoogle Scholar
  12. 12.
    Press N, Tyndall MW, Wood E, et al. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002; 31Suppl. 3: S112–7PubMedGoogle Scholar
  13. 13.
    Duggan J, Peterson WS, Schultz M, et al. Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDS 2001; 15: 159–67PubMedGoogle Scholar
  14. 14.
    Standish LJ, Greene KB, Bain S, et al. Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS Care 2001; 13: 197–208PubMedGoogle Scholar
  15. 15.
    Sparber A, Wootton JC, Bauer L, et al. Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials. J Altern Complement Med 2000; 6: 415–22PubMedGoogle Scholar
  16. 16.
    Greene KB, Berger J, Reeves C, et al. Most frequently used alternative and complementary therapies and activities by participants in the AMCOA study. J Assoc Nurses AIDS Care 1999; 10: 60–73PubMedGoogle Scholar
  17. 17.
    Rosenfeld B, Breitbart W, Stein K, et al. Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death. Am J Psychiatry 1999; 156: 94–100PubMedGoogle Scholar
  18. 18.
    Reilly CA, Holzmer WL, Henry SB, et al. A comparison of patient and nurse ratings of human immunodeficiency virus-related signs and symptoms. Nurs Res 1997; 46: 318–23PubMedGoogle Scholar
  19. 19.
    Fantoni M, Ricci F, Del Borgo C, et al. Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. J Palliat Care 1997; 13: 9–13PubMedGoogle Scholar
  20. 20.
    Hewitt D, McDonald M, Portenoy R, et al. Pain syndromes and etiologies in ambulatory AIDS patients. Pain 1997; 70: 117–23PubMedGoogle Scholar
  21. 21.
    Wesselmann U. Pain syndromes in AIDS. Anaesthesist 1996; 49: 1004–14Google Scholar
  22. 22.
    Holzemer WL, Henry SB, Reilly CA. Assessing and managing pain in AIDS care: the patient perspective. J Assoc Nurses AIDS Care 1998; 9: 22–30PubMedGoogle Scholar
  23. 23.
    Schifitto G, McDermott MP, McArthur JC, et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002; 58: 1764–8PubMedGoogle Scholar
  24. 24.
    Breitbart W, McDonald MV, Rosenfeld B, et al. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage 1998; 15: 159–67PubMedGoogle Scholar
  25. 25.
    Fontaine A, Larue F, Lassauniere JM. Physicians’ recognition of the symptoms experienced by HIV patients: how reliable? J Pain Symptom Manage 1999; 18: 263–70PubMedGoogle Scholar
  26. 26.
    Vogl D, Rosenfeld B, Breitbart W, et al. Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage 1999; 18: 253–62PubMedGoogle Scholar
  27. 27.
    van Servellen G, Sarna L, Jablonski KJ. Women with HIV: living with symptoms. West J Nurs Res 1998; 20: 448–64PubMedGoogle Scholar
  28. 28.
    Ferrando S, Evans S, Goggin K, et al. Fatigue in HIV illness: relationship to depression, physical limitations, and disability. Psychosom Med 1998; 60: 759–64PubMedGoogle Scholar
  29. 29.
    Rose LR, Pugh LC, Lears K, et al. The fatigue experience: persons with HIV infection. J Adv Nurs 1998; 28: 295–304PubMedGoogle Scholar
  30. 30.
    Ghani AC, Donnelly CA, Anderson RM. Patterns of antiretroviral use in the United States of America: analysis of three observational databases. HIV Med 2003; 4: 24–32PubMedGoogle Scholar
  31. 31.
    Newshan G, Bennett J, Holman S. Pain and other symptoms in ambulatory HIV patients in the age of highly active antiretroviral therapy. J Assoc Nurses AIDS Care 2002; 13: 78–83PubMedGoogle Scholar
  32. 32.
    Corless IB, Bunch EH, Kemppainen JK, et al. Self-care for fatigue in patients with HIV. Oncol Nurs Forum 2002; 29: E60–9PubMedGoogle Scholar
  33. 33.
    Doerfler RE. Sweetening the toxic cocktail: managing the side effects of HIV medications. Adv Nurse Pract 2002; 10: 52–103PubMedGoogle Scholar
  34. 34.
    Murri R, Ammassari A, De Luca A, et al. Self-reported nonadherence with antiretroviral drugs predicts persistent condition. HIV Clin Trials 2001; 2: 323–9PubMedGoogle Scholar
  35. 35.
    Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001; 28: 445–9PubMedGoogle Scholar
  36. 36.
    Reynolds NR, Neidig JL. Characteristics of nausea reported by HIV-infected patients initiating combination antiretroviral regimens. Clin Nurs Res 2002; 11: 71–88PubMedGoogle Scholar
  37. 37.
    Vosvick M, Koopman C, Gore-Felton C, et al. Relationship of functional quality of life to strategies for coping with the stress of living with HIV/AIDS. Psychosomatics 2003; 44: 51–8PubMedGoogle Scholar
  38. 38.
    Sullivan AK, Burton CT, Nelson MR, et al. Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Scand J Immunol 2003; 57: 600–7PubMedGoogle Scholar
  39. 39.
    Millikin CP, Rourke SB, Halman MH, et al. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. J Clin Exp Neuropsychol 2003; 25: 201–15PubMedGoogle Scholar
  40. 40.
    Galli M, Veglia F, Angarano G, et al. Gender differences in antiretroviral drug-related adipose tissue alterations: women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003; 34: 58–61PubMedGoogle Scholar
  41. 41.
    Power R, Tate HL, McGill SM, et al. A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sex Transm Infect 2003; 79: 137–41PubMedGoogle Scholar
  42. 42.
    Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read 2000; 10: 546–50PubMedGoogle Scholar
  43. 43.
    Craig T, Kakumanu S. Chronic fatigue syndrome: evaluation and treatment. Am Fam Physician 2002; 65: 1083–90PubMedGoogle Scholar
  44. 44.
    Monchamp T, Frishman WH. Exercise as a treatment modality for congestive heart failure. Heart Dis 2002; 4: 110–6PubMedGoogle Scholar
  45. 45.
    Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception, and activity level of subjects with multiple sclerosis. Mult Scler 2002; 8: 161–8PubMedGoogle Scholar
  46. 46.
    Mock V, Pickett M, Ropka ME, et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 2001; 9: 119–27PubMedGoogle Scholar
  47. 47.
    Ambrose K, Lyden AK, Clauw DJ. Applying exercise to the management of fibromyalgia. Curr Pain Headache Rep 2003; 7: 348–54PubMedGoogle Scholar
  48. 48.
    Oldervoll LM, Kaasa S, Knobel H, et al. Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors: results from a pilot study. Eur J Cancer 2003; 39: 57–63PubMedGoogle Scholar
  49. 49.
    Monga U, Garber SL, Thornby J, et al. Role of exercise to prevent fatigue and improve quality of life in localized prostate cancer patients undergoing radiation therapy. Int J Radiat Oncol Biol Phys 2003; 57 (2 Suppl.): S445Google Scholar
  50. 50.
    Sarna L, Conde F. Physical activity and fatigue during radiation therapy: a pilot study using actigraph monitors. Oncol Nurs Forum 2001; 28: 1043–6PubMedGoogle Scholar
  51. 51.
    Shwartz AL. Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract 2000; 8: 16–24Google Scholar
  52. 52.
    Courneya KS, Friedenreich CM. Physical exercise and quality of life following cancer diagnosis: a literature review. Ann Behav Med 1999; 21: 171–9PubMedGoogle Scholar
  53. 53.
    Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997; 24: 991–1000PubMedGoogle Scholar
  54. 54.
    Oka RK, De Marco T, Haskell WL, et al. Impact of a home-based walking and resistance training program on quality of life in patients with heart failure. Am J Cardiol 2000; 85: 365–9PubMedGoogle Scholar
  55. 55.
    Morgan WP. Affective beneficence of vigorous physical activity. Med Sci Sports Exerc 1985; 17: 94–100PubMedGoogle Scholar
  56. 56.
    Thayer RE. Energy, tiredness, and tension effects of a sugar snack versus moderate exercise. J Pers Soc Psychol 1987; 52: 119–25PubMedGoogle Scholar
  57. 57.
    Gimenez M, Servera E, Vergara P, et al. Endurance training in patients with chronic obstructive pulmonary disease: a comparison of high versus moderate intensity. Arch Phys Med Rehabil 2000; 81: 102–9PubMedGoogle Scholar
  58. 58.
    Rooyackers JM, Folgering HT. Cardio-respiratory load of exercise training in patients with severe COPD. Int J Rehabil Res 1998; 21: 259–71PubMedGoogle Scholar
  59. 59.
    Alfaro V, Torras R, Prats MT, et al. Improvement in exercise tolerance and spirometric values in stable chronic obstructive pulmonary disease patients after an individualized outpatient rehabilitation programme. J Sports Med Phys Fitness 1996; 36: 195–203PubMedGoogle Scholar
  60. 60.
    Celli BR. Current thoughts regarding treatment of chronic obstructive pulmonary disease. Med Clin North Am 1996; 80: 589–609PubMedGoogle Scholar
  61. 61.
    Janal MN, Colt EWD, Clark WC, et al. Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: effects of naloxone. Pain 1984; 19: 13–25PubMedGoogle Scholar
  62. 62.
    Droste C, Greenlee MW, Schreck M, et al. Experimental pain thresholds and plasma beta-endorphin levels during exercise. Med Sci Sports Exerc 1991; 23: 334–42PubMedGoogle Scholar
  63. 63.
    Bartholomew JB, Lewis BP, Linder DE, et al. Post-exercise analgesia: replication and extension. J Sports Sci 1996; 14: 329–34PubMedGoogle Scholar
  64. 64.
    Koltyn KF, Arbogast RW. Perception of pain after resistance exercise. Br J Sports Med 1998; 32: 20–4PubMedGoogle Scholar
  65. 65.
    Koltyn KF. Exercise-induced hypoalgesia and intensity of exercise. Sports Med 2002; 32: 477–87PubMedGoogle Scholar
  66. 66.
    Busch A, Schachter CL, Peloso PM, et al. Exercise for treating fibromyalgia syndrome. Cochrane Database System Review 2002; (3): CD003786Google Scholar
  67. 67.
    Winningham ML, Mac Vicar MG. The effect of aerobic exercise on patient reports of nausea. Oncol Nurs Forum 1988; 15: 447–50PubMedGoogle Scholar
  68. 68.
    Glace BW, Murphy CA, McHugh MP. Food intake and electrolyte status of ultramarathoners competing in extreme heat. J Am Coll Nutr 2002; 21: 553–9PubMedGoogle Scholar
  69. 69.
    Simren M. Physical Activity and the gastrointestinal tract. Eur J Gastroenterol Hepatol 2002; 14: 1053–6PubMedGoogle Scholar
  70. 70.
    Kugler J, Seelbach H, Kruskemper GM. Effects of rehabilitation exercise programmes on anxiety and depression in coronary patients: a meta-analysis. Br J Clin Psychol 1994; 33: 401–10PubMedGoogle Scholar
  71. 71.
    Segar ML, Katch VL, Roth RS, et al. The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncol Nurs Forum 1998; 25: 107–12PubMedGoogle Scholar
  72. 72.
    Gowans SE, deHueck A, Abbey SE. Measuring exercise-induced mood changes in fibromyalgia: a comparison of several measures. Arthritis Rheum 2002; 47: 603–9PubMedGoogle Scholar
  73. 73.
    Carney RM, McKevitt PM, Goldberg AP, et al. Psychological effects of exercise training in hemodialysis patients. Nephron 1983; 33: 179–81PubMedGoogle Scholar
  74. 74.
    Petajan JH, Gappmaier E, White AT, et al. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996; 39: 432–41PubMedGoogle Scholar
  75. 75.
    Milani RV, Lavie CJ, Cassidy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 1996; 132: 726–32PubMedGoogle Scholar
  76. 76.
    Gowans SE, deHueck A, Voss S, et al. Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Rheum 2001; 45: 519–29PubMedGoogle Scholar
  77. 77.
    Emery CF, Schein RL, Hauck ER, et al. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 1998; 17: 232–40PubMedGoogle Scholar
  78. 78.
    Suh MR, Jung HH, Kim SB, et al. Effects of regular exercise on anxiety, depression, and quality of life in maintenance hemodialysis patients. Ren Fail 2002; 24: 337–45PubMedGoogle Scholar
  79. 79.
    Blanchard CM, Courneya KS, Laing D. Effects of acute exercise on state anxiety in breast cancer survivors. Oncol Nurs Forum 2001; 28: 1617–21PubMedGoogle Scholar
  80. 80.
    Burnham TR, Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc 2002; 34: 1863–7PubMedGoogle Scholar
  81. 81.
    Bartholomew JB, Miller BM. Affective responses to an aerobic dance class: the impact of perceived performance. Res Q Exerc Sport 2002; 73: 301–9PubMedGoogle Scholar
  82. 82.
    Tuscon KM, Sinyor D. On the affective benefits of acute aerobic exercise: taking stock after twenty years of research. In: Sereganian P, editor. Exercise psychology: the influence of physical exercise on psychological processes. New York: John Wiley & Sons, 1993: 80–121Google Scholar
  83. 83.
    Hicks AL, Martin KA, Ditor DS, et al. Long-term exercise training in persons with spinal cord injury effects on strength, arm ergometry performance and psychological well-being. Spinal Cord 2003; 41: 34–43PubMedGoogle Scholar
  84. 84.
    Rigsby LW, Dishman RK, Jackson AW, et al. Effects of exercise training on men seropositive for the human immunodeficiency virus-1. Med Sci Sports Exerc 1992; 24: 6–12PubMedGoogle Scholar
  85. 85.
    MacArthur RD, Levine SD, Birk TJ. Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc 1993; 25: 684–8PubMedGoogle Scholar
  86. 86.
    Stringer WW. HIV and aerobic exercise: current recommendations. Sports Med 1999; 28: 389–95PubMedGoogle Scholar
  87. 87.
    Stringer WW, Berezovskaya M, O’Brien WA, et al. The effect of exercise training on aerobic fitness, immune indicies, and quality of life in HIV+ patients. Med Sci Sports Exerc 1998; 30: 11–6PubMedGoogle Scholar
  88. 88.
    Perna F, LaPerriere A, Klimas N, et al. Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection. Med Sci Sports Exerc 1999; 31: 973–9PubMedGoogle Scholar
  89. 89.
    Smith BA, Neidig JL, Nickel JT, et al. Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS 2001; 15: 693–701PubMedGoogle Scholar
  90. 90.
    Grinspoon S, Corcoran C, Parlman K, et al. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting: a randomized, controlled trial. Ann Intern Med 2000; 133: 348–55PubMedGoogle Scholar
  91. 91.
    Fairfield WP, Finkelstein JS, Klibanski A, et al. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab 2001; 86: 2020–6PubMedGoogle Scholar
  92. 92.
    Fairfield WP, Treat M, Rosenthal DI, et al. Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J Appl Physiol 2001; 90: 2166–71PubMedGoogle Scholar
  93. 93.
    Wagner G, Rabkin J, Rabkin R. Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV+ men. Med Sci Sports Exerc 1998; 30: 811–7PubMedGoogle Scholar
  94. 94.
    Bhasin S, Storer TW, Javanbakht M, et al. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 2000; 283: 763–70PubMedGoogle Scholar
  95. 95.
    Yarasheski KE, Tebas P, Stanerson B, et al. Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy. J Appl Physiol 2001; 90: 133–8PubMedGoogle Scholar
  96. 96.
    Roubenoff R, McDermott A, Weiss L, et al. Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus. AIDS 1999; 13: 231–9PubMedGoogle Scholar
  97. 97.
    Roubenoff R. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life. Am J Manag Care 2000; 6: 1003–16PubMedGoogle Scholar
  98. 98.
    Roubenoff R, Wilson IB. Effect of resistance training on self reported physical functioning in HIV infection. Med Sci Sports Exerc 2001; 33: 1811–7PubMedGoogle Scholar
  99. 99.
    Agin D, Gallagher D, Wang J, et al. Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV. AIDS 2001; 15: 2431–40PubMedGoogle Scholar
  100. 100.
    Agin D, Kotler DP, Papandreou D, et al. Effects of whey protein and resistance exercise on body composition and muscle strength in women with HIV infection. Ann N Y Acad Sci 2000; 904: 607–9PubMedGoogle Scholar
  101. 101.
    Yarasheski KE, Roubenoff R. Exercise treatment for HIV-associated metabolic and anthropomorphic complications. Exerc Sport Sci Rev 2001; 29: 170–4PubMedGoogle Scholar
  102. 102.
    Jones SP, Doran DA, Leatt PB, et al. Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy. AIDS 2001; 15: 2049–51PubMedGoogle Scholar
  103. 103.
    Thoni GJ, Fedou C, Brun JF, et al. Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia. Diabetes Metab 2002; 28: 397–404PubMedGoogle Scholar
  104. 104.
    Roubenoff R, Weiss L, McDermott A, et al. A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 1999; 13: 1373–5PubMedGoogle Scholar
  105. 105.
    Mustafa T, Sy FS, Macera CA, et al. Association between exercise and HIV disease progression in a cohort of homosexual men. Ann Epidemiol 1999; 9: 127–31PubMedGoogle Scholar
  106. 106.
    Neidig JL, Smith BA, Brashers DE. Aerobic exercise training for depressive symptom management in adults living with HIV infection. J Assoc Nurses AIDS Care 2003; 14: 30–40PubMedGoogle Scholar
  107. 107.
    Terry L, Sprinz E, Ribeiro JP. Moderate and high intensity exercise training in HIV-1 seropositive individuals: a randomized trial. Int J Sports Med 1999; 20: 142–6PubMedGoogle Scholar
  108. 108.
    Lox CL, McAuley E, Tucker S. Physical training effects on acute exercise-induced feeling states in HIV-1 positive individuals. J Health Psychol 1996; 1: 235–40PubMedGoogle Scholar
  109. 109.
    Lox CL, McAuley E, Tucker S. Exercise as an intervention for enhancing subjective well-being in an HIV-1 population. J Sport Exerc Psychol 1995; 17: 345–62Google Scholar
  110. 110.
    Schlenzig C, Jager H, Rieder H. Supervised physical exercise leads to psychological and immunological improvement in pre-AIDS patients. Preceedings of the 5th International AIDS Conference; 1989 Jun 4–9; Montreal, 337Google Scholar
  111. 111.
    Nicholas PK, Kemppainen JK, Holzerner WL, et al. Self-care management for neuropathy in HIV disease. AIDS Care 2002; 14: 763–71PubMedGoogle Scholar
  112. 112.
    LaPerriere AR, Antoni MH, Schneiderman N, et al. Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self Regul 1990; 15: 229–42PubMedGoogle Scholar
  113. 113.
    Rejeski WJ, Gauvin L, Hobson ML, et al. Effects of baseline responses, in-task feelings, and duration of activity on exercise-induced feeling states in women. Health Psychol 1995; 14: 350–9PubMedGoogle Scholar
  114. 114.
    Bopp CM, Phillips KD, Fulk LJ, et al. Clinical implications of therapeutic exercise in HIV/AIDS. J Assoc Nurses AIDS Care 2003; 14: 73–8PubMedGoogle Scholar
  115. 115.
    Malina RM. Adherence to physical activity from childhood to adulthood: a perspective from tracking studies. Quest 2001; 53: 346–55Google Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Joseph T. Ciccolo
    • 1
    Email author
  • Esbelle M. Jowers
    • 1
  • John B. Bartholomew
    • 1
  1. 1.Exercise Psychology LaboratoryThe University of Texas at AustinAustinUSA

Personalised recommendations